Medical isotopes. Global importance and opportunities for the Netherlands in a European context
|Classificatie||6.07.4.60/37 (ALLERLEI - NUCLEAIRE GENEESKUNDE - MEDISCHE ISOTOPEN)|
Uit de publicatie:
Medical isotopes Global importance and opportunities for the Netherlands in a European context November 2017 Nucleair Nederland, Nuclear Netherlands Foreword This publication highlights the importance of continuous and reliable supply of medical isotopes to the Netherlands, Europe and the rest of the world. It also describes the substantial efforts taken by all supply chain partners towards breakthroughs that improve future nuclear health care services and treatment of patients. The development of new therapeutic applications of isotopes is illustrated with several examples. The Netherlands has an internationally recognised unique position: it is the world’s largest supplier of molybdenum-99/ technetium-99m, it hosts all supply chain partners within its borders, it has a long tradition in supply chain collaboration, it is a renowned developer of new international breakthroughs in new therapy and diagnostics and it is progressing well on the new multi- functional facility for medical isotopes, the PALLAS-reactor, the core of the infrastructure for the decades to come.